A Perspective on the Evolving Landscape in Male Reproductive Medicine
March 2016
in “
The Journal of Clinical Endocrinology and Metabolism
”
TLDR Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.
The document from March 1, 2016, provides an overview of the progress and challenges in male reproductive medicine. It discusses advancements in treating conditions like erectile dysfunction, infertility, and hormone-sensitive cancers, but also highlights areas needing improvement such as the management of androgen deficiency syndromes, with a call for accurate testosterone assays and large randomized trials. The document raises concerns about the health risks of anabolic-androgenic steroid use, the need for better healthcare for transgender persons, and the lack of conclusive evidence on the long-term benefits and risks of testosterone therapy, particularly in middle-aged and older men. It also points out the need for better fertility regulation options, understanding of gynecomastia, and research on hormonal contraceptives for men. The paper emphasizes the importance of integrating translational science with patient-focused healthcare and predicts that societal attitudes and economics will shape the future of research funding and healthcare delivery in this field. The author, Shalender Bhasin, discloses his affiliations and potential conflicts of interest related to his work in the field.
